ICD Scrutiny: Study Quantifies Significant Off-Guideline Implant Activity
The implantable defibrillator sector took another potential hit last week with findings that more than 20% of patients treated with the devices for primary prevention of sudden cardiac death should not receive them under current guidelines.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
